Expression profiling of macrophages from subjects with atherosclerosis to identify novel susceptibility genes

International Journal of Molecular Medicine

Volumn 21, Issue 6, 2008, Pages 697-704

  Hägg, Daniel A ^a,d   Jernås, Margareta ^a   Wiklund, Olle ^a   Thelle, Dag S ^b   Fagerberg, Björn ^a   Eriksson, Per ^c   Hamsten, Anders ^c   Olsson, Bob ^a   Carlsson, Björn ^a   Carlsson, Lena M S ^a   Svensson, Per Arne ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF OSLO   (Norway)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d NONE   (Sweden)

Author keywords

Atherosclerosis; Foam cells; Genomics; Genotyping; IRS2; Macrophages

Indexed keywords

CARRIER PROTEIN; CD86 ANTIGEN; CYTOSINE; INSULIN RECEPTOR SUBSTRATE 2; SOLUTE CARRIER FAMILY 11 MEMBER 1 PROTEIN; THYMINE; UNCLASSIFIED DRUG; CATION TRANSPORT PROTEIN; CD44 PROTEIN, HUMAN; CD86 PROTEIN, HUMAN; HERMES ANTIGEN; INSULIN RECEPTOR SUBSTRATE 2 PROTEIN; INSULIN RECEPTOR SUBSTRATE-2 PROTEIN; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; NATURAL RESISTANCE-ASSOCIATED MACROPHAGE PROTEIN 1; PHOSPHOPROTEIN; SIGNAL PEPTIDE;

ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CAROTID ARTERY DISEASE; CONTROLLED STUDY; ENDOTHELIUM CELL; FOAM CELL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HIGH RISK POPULATION; HOMOZYGOTE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; ISCHEMIC HEART DISEASE; MACROPHAGE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; ALLELE; CYTOLOGY; DNA MICROARRAY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK; RISK FACTOR;

ALLELES; ANTIGENS, CD44; ANTIGENS, CD86; ATHEROSCLEROSIS; CATION TRANSPORT PROTEINS; ENDOTHELIAL CELLS; FOAM CELLS; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROPHAGES; ODDS RATIO; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHOPROTEINS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS;

EID: 47649105223     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.21.6.697     Document Type: Article

References (28)

1. Lusis AJ, Mar R and Pajukanta P: Genetics of atherosclerosis. Annu Rev Genomics Hum Genet 5: 189-218, 2004.
2. Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group. BMJ 303: 893-896, 1991.
3. Seo D, Ginsburg GS and Goldschmidt-Clermont PJ: Gene expression analysis of cardiovascular diseases: novel insights into biology and clinical applications. J Am Coll Cardiol 48: 227-235, 2006.
4. Cowles CR, Hirschhorn JN, Altshuler D and Lander ES: Detection of regulatory variation in mouse genes. Nat Genet 32: 432-437, 2002.
5. Berg C, Rosengren A, Aires N, et al: Trends in overweight and obesity from 1985 to 2002 in Göteborg, West Sweden. Int J Obes 29: 916-924, 2005.
6. Hägg D, Sjoberg S, Hulten LM, et al: Augmented levels of CD44 in macrophages from atherosclerotic subjects: A possible IL-6-CD44 feedback loop? Atherosclerosis 190: 291-297, 2006.
7. Svensson PA, Englund MC, Snackestrand MS, et al: Regulation and splicing of scavenger receptor class B type I in human macrophages and atherosclerotic plaques. BMC Cardiovasc Disord 5: 25, 2005.
8. Steinberg D: Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 272: 20963-20966, 1997.
9. Hägg D, Englund MC, Jernas M, et al: Oxidized LDL induces a coordinated up-regulation of the glutathione and thioredoxin systems in human macrophages. Atherosclerosis 185: 282-289, 2006.
10. Buono C, Pang H, Uchida Y, Libby P, Sharpe AH and Lichtman AH: B7-1/B7-2 costimulation regulates plaque antigen-specific T-cell responses and atherogenesis in low-density lipoprotein receptor-deficient mice. Circulation 109: 2009-2015, 2004.
11. Baumgartl J, Baudler S, Schemer M, et al: Myeloid lineage cell-restricted insulin resistance protects apolipoproteinE-deficient mice against atherosclerosis. Cell Metab 3: 247-256, 2006.
12. Chiodini BD and Lewis CM: Meta-analysis of 4 coronary heart disease genome-wide linkage studies confirms a susceptibility locus on chromosome 3q. Arterioscler Thromb Vasc Biol 23: 1863-1868, 2003.
13. Iwamoto K, Mori H, Okazawa H, Hashiramoto M and Kasuga M: Identification of a single nucleotide polymorphism showing no insulin-mediated suppression of the promoter activity in the human insulin receptor substrate 2 gene. Diabetologia 45: 1192-1195, 2002.
14. Searle S and Blackwell JM: Evidence for a functional repeat polymorphism in the promoter of the human NRAMP1 gene that correlates with autoimmune versus infectious disease susceptibility. J Med Genet 36: 295-299, 1999.
15. Ait-Oufella H, Salomon BL, Potteaux S, et al: Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 12: 178-180, 2006.
16. Samani NJ, Erdmann J, Hall AS, et al: Genomewide association analysis of coronary artery disease. N Engl J Med 357: 443-453, 2007.
17. Helgadottir A, Thorleifsson G, Manolescu A, et al: A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 316: 1491-1493, 2007.
18. McPherson R, Pertsemlidis A, Kavaslar N, et al: A common allele on chromosome 9 associated with coronary heart disease. Science 316: 1488-1491, 2007.
19. Nagy L, Tontonoz P, Alvarez JG, Chen H and Evans RM: Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 93: 229-240, 1998.
20. Smith U, Gogg S, Johansson A, Olausson T, Rotter V and Svalstedt B: Thiazolidinediones (PPARgamma agonists) but not PPARalpha agonists increase IRS-2 gene expression in 3T3-L1 and human adipocytes. FASEB J 15: 215-220, 2001.
21. Yeh M, Cole AL, Choi J, et al: Role for sterol regulatory element-binding protein in activation of endothelial cells by phospholipid oxidation products. Circ Res 95: 780-788, 2004.
22. Ide T, Shimano H, Yahagi N, et al: SREBPs suppress IRS-2-mediated insulin signalling in the liver. Nat Cell Biol 6: 351-357, 2004.
23. White MF: The IRS-signaling system: a network of docking proteins that mediate insulin and cytokine action. Recent Prog Horm Res 53: 119-138, 1998.
24. Kubota T, Kubota N, Moroi M, et al: Lack of insulin receptor substrate-2 causes progressive neointima formation in response to vessel injury. Circulation 107: 3073-3080, 2003.
25. Clough MH, Schneider DJ, Sobel BE, White MF, Wadsworth MP and Taatjes DJ: Attenuation of accumulation of neointimal lipid by pioglitazone in mice genetically deficient in insulin receptor substrate-2 and apolipoprotein e. J Histochem Cytochem 53: 603-610, 2005.
26. Sadagurski M, Weingarten G, Rhodes CJ, White MF and Wertheimer E: Insulin receptor substrate 2 plays diverse cell-specific roles in the regulation of glucose transport. J Biol Chem 280: 14536-14544, 2005.
27. Lautier C, El Mkadem SA, Renard E, et al: Complex haplotypes of IRS2 gene are associated with severe obesity and reveal heterogeneity in the effect of Gly1057Asp mutation. Hum Genet 113: 34-43, 2003.
28. Mammarella S, Romano F, Di Valerio A, et al: Interaction between the G1057D variant of IRS-2 and overweight in the pathogenesis of type 2 diabetes. Hum Mol Genet 9: 2517-2521, 2000.